ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.81
+0.18 (2.09%)
At close: Oct 28, 2026, 4:00 PM EDT
8.84
+0.03 (0.34%)
Pre-market: Oct 29, 2026, 6:36 AM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $9.34 billion as of October 28, 2026. It is the 2,248th most valuable company in the world and the 808th biggest in the United States. Its market cap has increased by 256.38% in one year.
Market Cap
9.34B
Enterprise Value
10.21B
1-Year Change
256.38%
Global Rank
Country Rank
#808 United States
Category
ChartMarket Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $9.34B, a decrease of -37.01%. That is a compound annual growth rate of -7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 9.34B | 378.77% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 9.51B |
| Corcept Therapeutics | 9.28B |
| Krystal Biotech | 9.22B |
| Kymera Therapeutics | 9.21B |
| Caris Life Sciences | 9.04B |
| Protagonist Therapeutics | 8.96B |
| Twist Bioscience | 8.77B |
| Cytokinetics | 8.51B |